The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results, is ...

In a new study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

The neurorehabilitation devices market is expected to grow from US$ 2.73 billion in 2023, with CAGR of 12.7% during 2023–2031 ...

such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the ...

Your doctor will ensure that the needle is positioned between your spinal cord and the cord’s covering or the meninges when drawing fluid. The whole procedure typically takes about 15 to 20 ...